Lundbeck   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Copenhagen Denmark (1915)

Organization Overview

First Clinical Trial
1989
NCT01353807
First Marketed Drug
1962
stanozolol (winstrol)
First NDA Approval
1962
stanozolol (winstrol)
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

H. Lundbeck A/S | H. Lundbeck A/S, TEVA | LuncbeckClinicalTrials@Lundbeck.com | Lundbech Foundation | Lundbeck Canada Inc. | LundbeckClinicalTrials.com | LundbeckClinicalTrials@lundbeck.com | LundbeckClinicalTrials@Lundbeck.com | Lundbeck Foundation | Lundbeck France | Lundbeck GmbH, Ericusspitze 2, 20457 Hamburg | LUNDBECK INC | Lundbeck Israel | Lundbeck Italia S.p.A. | Lundbeck Japan K. K. | Lundbeck LLC | LUNDBECK NA LTD | Lundbeck Northera Ltd. | LUNDBECK PHARMS LLC | Lundbeck Seattle BioPharmaceuticals, Inc.